Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model

Annals of Thoracic Surgery

Volumn 80, Issue 1, 2005, Pages 251-257

  Kondo, Norihiro ^a,b   Suzuki, Yasuyuki ^a   Wakayama, Fuminori ^a   Tamai, Yoshiko ^a   Ji, Kaiqiang ^a   Fukui, Kozo ^a   Fukuda, Ikuo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 AMIDINOPHENOXY)BUTYRYLASPARTYLVALINE; ADENOSINE DIPHOSPHATE; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PADGEM PROTEIN; THROMBIN ANTITHROMBIN COMPLEX;

ARTICLE; BLEEDING TIME; BLOOD CELL COUNT; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; EVALUATION; FLOW CYTOMETRY; HEMATOCRIT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; STERNOTOMY; SURGICAL DRAINAGE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; WOUND CLOSURE;

ANIMALS; BLOOD PLATELETS; CARDIOPULMONARY BYPASS; DIPEPTIDES; DISEASE MODELS, ANIMAL; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SWINE;

EID: 20544458137     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.02.020     Document Type: Article

References (29)

1. F. Bizzarri, S. Scolletta, E. Tucci Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting J Thorac Cardiovasc Surg 122 2001 1181 1185
2. R.C. Woodman, L.A. Harker Bleeding complication associated with cardiopulmonary bypass Blood 76 1990 1680 1697
3. K. Tanaka, M. Takao, I. Yada, H. Yuasa, M. Kugasawa, K. Deguchi Alteration in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery J Cardiothorac Anesth 3 1989 181 188
4. Y. Hiramatsu, N. Gikakis, H.L. Anderson 3rd Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons J Thorac Cardiovasc Surg 113 1997 182 193
5. Y. Suzuki, P. Hillyer, S. Miyamoto Integrilin prevents prolonged bleeding times after cardiopulmonary bypass Ann Thorac Surg 66 1998 373 381
6. Y. Suzuki, R. Malekan, C.W. Hanson III Platelet anesthesia with nitric oxide with or without eptifibatide during cardiopulmonary bypass in baboons J Thorac Cardiovasc Surg 117 1999 987 993
7. E. Ruoslahti Integrins J Clin Invest 87 1991 1 5
8. E.W. Muriithi, P.R. Belcher, J.N. Rao, M.A. Chaudhry, D. Nicol, D.J. Wheatley The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass J Thorac Cardiovasc Surg 120 2000 538 543
9. M.K. Dewanjee, V.V. Belinskiy, J.F. Holland Effect of thoracotomy and cardiopulmonary bypass on activated platelet and neutrophil dynamics and platelet emboli in a pig model J Thromb Thrombolysis 3 1996 195 208
10. F. De Somer, Y. Van Belleghem, F. Caes Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass J Thorac Cardiovasc Surg 123 2002 951 958
11. T. Aoki, D. Cox, K. Senzaki The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIB/IIIA antagonist Thromb Res 81 1996 439 450
12. T. Aoki, K. Harada, J. Seki FK633:a potent and selective platelet GP IIb/IIIa antagonist Cardiovasc Drug Rev 17 1999 147 159
13. N. Kondo, F. Wakayama, Y. Suzuki, K. Fukui, S. Takaya, I. Fukuda The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor Thromb Res 113 2004 303 310
14. M.F. Hoylaerts Amplification loops release reaction P. Greesele G. Page V. Fuster J. Vermylem Platelets in thrombotic and non-thrombotic disorders 2002 Cambridge University Press Cambridge, UK 357 368
15. A.D. Michelson Flow cytometry a clinical test of platelet function Blood 87 1996 4925 4936
16. Removal of blood from laboratory mammals and birds. First report of the BVA/FRAME/RSPCA/UFAW Joint Working Group on Refinement Lab Anim 27 1993 1 22
17. C. Dyke, D. Bhatia Inhibitors of the platelet receptor glycoprotein IIb-IIIa and complications during percutaneous coronary revascularization. Management strategies for the cardiac surgeon J Cardiovasc Surg 40 1999 505 516
18. K. Schror, A.A. Weber Comparative pharmacology of GP IIb/IIIa antagonists J Thromb Thrombolysis 15 2003 71 80
19. H. Tanaka, H. Yoshino, E. Kobayashi Molecular investigation of hepatitis E virus infection in domestic and miniature pigs used fore medical experiments Xenotransplantation 11 2004 503 510
20. M.K. Dewanjee, M. Kapadvanjwala, A. Sanchez Quantitation of comparative thrombogenicity of dog, pig, and human platelets in a hemodialyzer ASAIO J 38 1992 88 90
21. A. Larsson, M. Eriksson, T. Lundahl, K. Lundkvist, T. Lindahl Impaired platelet function in analyzed by flow cytometry endotoxemic pigs Platelets 9 1998 115 119
22. A. Larsson, T. Lundahl, M. Eriksson, K. Lundkvist, T. Lindahl Endotoxin induced platelet microvesicle formation measured by flow cytometry Platelets 7 1996 153 158
23. H. Suhara, Y. Sawa, M. Nishimura Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model Ann Thorac Surg 71 2001 1603 1608
24. L.H. Edmunds Blood platelets and bypass J Thorac Cardiovasc Surg 97 1989 470 471
25. R.K. Wenger, H. Lukasiewicz, B.S. Mikuta, S. Niewiarowski, L.H. Edmunds Jr Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass J Thorac Cardiovasc Surg 97 1989 235 239
26. S. Kanemitsu, M. Nishikawa, K. Onoda Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation J Thorac Cardiovasc Surg 126 2003 428 435
27. J.H. Levy, K.A. Tanaka Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 75 Suppl 2003 S715 S720
28. A.K. Rao, L. Sun, Y. Hiramatsu, J.H. Gorman 3rd, L.H. Edmunds Jr Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons Thromb Haemost 82 1999 140 144
29. T.V. Byzova, E.F. Plow Activation of alphaVbeta3 on vascular cells controls recognition of prothrombin J Cell Biol 143 1998 2081 2092